Enantioselective disposition of salbutamol in man following oral and intravenous administration

British Journal of Clinical Pharmacology

Volumn 41, Issue 1, 1996, Pages 35-40

  Boulton, D W ^a   Fawcett, J P ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Albuterol; Enantiomers; Enantioselective metabolism; Pharmacokinetics; Salbutamol

Indexed keywords

SALBUTAMOL;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG EXCRETION; DRUG METABOLISM; DRUG URINE LEVEL; ENANTIOMER; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEREOSPECIFICITY;

EID: 0030044446     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1996.tb00156.x     Document Type: Article

References (25)

1. Price AH, Clissold SP. Salbutamol in the 1980s. A reappraisal of its clinical efficacy. Drugs 1989; 38: 77-122.
2. Brittain RT, Farmer JB, Marshall RJ. Some observations on the β-adrenoceptor agonist properties of the isomers of salbutamol. Br J Pharmacol 1973; 48: 144-147.
3. Evans ME, Walker SR, Brittain RT, Paterson JW. The metabolism of salbutamol in man. Xenobiotica 1973; 3: 113-120.
4. Morgan DJ, Paull JD, Richmond BH, Wilson-Evered E, Ziccone SP. Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. Br J Clin Pharmacol 1986; 22: 587-593.
5. Goldstein DA, Tan YK, Soldin SJ. Pharmacokinetic and absolute bioavailability of salbutamol in healthy adult volunteers. Eur J Clin Pharmacol 1987; 32: 631-634.
6. Baba S, Goromaru T, Kawaguchi I, Kishi K. Urinary excretion of salbutamol enantiomers in man by stable isotope tracer technique. Iyakuhin Kenkyu 1981; 12: 84-90.
7. Tan YK, Soldin SJ. Analysis of salbutamol enantiomers in human urine by chiral high-performance liquid chromatography and preliminary studies related to the stereoselective disposition kinetics in man. J Chromatogr 1987; 442: 187-195.
8. 2-agonist drug albuterol by the human liver. Res Commun Chem Pathol Pharmacol 1992; 75: 125-128.
9. Walle UK, Pesola GR, Walle T. Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity. Br J Clin Pharmacol 1993; 35: 413-8.
10. Walle T, Walle UK, Thornburg KR, Schey KL. Stereoselective sulfation of albuterol in humans. Biosynthesis of the sulfate conjugate by HEP G2 cells. Drug Metab Dispos Biol Fate Chem 1993; 21: 76-80.
11. Borgström L, Nyberg L, Jönsson S, Lindberg C, Paulson J. Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate. Br J Clin Pharmacol 1989; 27: 49-56.
12. Borgström L, Kennedy BM, Nilsson B, Angelin B. Relative absorption of the two enantiomers of terbutaline after duodenal administration. Eur J Clin Pharmacol 1990; 38: 621-623.
13. Boulton DW, Fawcett JP. Determination of salbutamol enantiomers in human plasma and urine by chiral high pressure liquid chromatography. J Chromatogr B (in press).
14. Bland RE, Tanner RJN, Chern WH, Lang JR, Powell JR. Determination of albuterol concentrations in human plasma using solid-phase extraction and high-performance liquid chromatography with fluorescence detection. J Pharm Biomed Anal 1990; 8: 591-596.
15. 3H: A new bronchodilator, in rat, rabbit, dog and man. Eur J Pharmacol 1971; 14: 183-199.
16. Walker SR, Evans ME, Richards AJ, Paterson JW. The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther 1972; 13: 861-867.
17. Powell ML, Weisberger M, Gural R, et al. Comparative bioavailability and pharmacokinetics of three formulations of albuterol. J Pharm Sci 1985; 74: 217-219.
18. Vaisman N, Koren G, Goldstein D, et al. Pharmacokinetics of inhaled salbutamol in patients with cystic fibrosis versus healthy young adults. J Pediatrics 1987; 111: 914-917.
19. Powell ML, Chung M, Weisberger M, et al. Multiple-dose albuterol kinetics. J Clin Pharmacol 1986; 26: 643-646.
20. Hussey EK, Donn KH, Powell JR, Lahey AP, Pakes GE. Albuterol extended-release products: Effect of food on the pharmacokinetics of single oral doses of Volmax® and Proventil® Repetabs® in healthy male volunteers. J Clin Pharmacol 1991; 31: 561-564.
21. Lipworth BJ, Clark RA, Dhillon DP, et al. Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol 1989; 37: 567-571.
22. Bai SA, Walle UK, Wilson MJ, Walle T. Stereoselective binding of the (-) enantiomer of propranolol to plasma and extravascular binding sites in the dog. Drug Metab Dispos 1983; 11: 394-399.
23. Walle T, Webb JG, Bagwell EE, Walle UK, Daniell HB, Gaffney TE. Stereoselective delivery and actions of beta receptor antagonists. Biochem Pharmacol 1988; 37: 115-124.
24. Kurosawa N, Owada E, Kato A, Bando K, Ito K, Kurosawa S. Serum concentration and cardiovascular effects of salbutamol after oral and rectal administration in healthy volunteers. J Clin Pharmacol Ther 1993; 18: 103-108.
25. Morley J, Chapman ID, Foster A, Hoshiko K, Mazzoni L. Effects of (+) and racemic salbutamol on airway responses in the guinea-pig. Br J Pharmacol 1991; 104: 295P.